Blog

The Food and Drug Administration (FDA) authorized the use of the Pfizer-BioNTech pediatric COVID-19 vaccine for 5 to 11 years old. The agency said that the decision was based on data from a clinical trial showing that this lower-dose vaccine was 90.7 percent effective for preventing the COVID-19 in this age group. In addition, no…

The mix-and-match approach to COVID-19 vaccines by using different brands for first and second doses- appears to offer good protection against the pandemic virus, a study in the UK has found. The Com-Cov trial looked at the efficacy of either two doses of AstraZeneca, two of Pfizer, or one of them followed by the other.…

It was heartbreaking to watch dozens of Olympic athletes having their dream crashed with the novel coronavirus taking the wheel. Many tested positive for the COVID-19 and have been ruled out even after their doses of vaccination. Doctors, however, are not surprised by the test results coming out positive. In most cases, they prevent someone…

There have been many misconceptions, conspiracy theories, and myths about the COVID-19 vaccine that continue to circulate online. In this blog, you can find some of them and get your facts checked: Myth: Vaccines do not work Former CDC chief medical officer and dean of New York Medical College School of Health Sciences and Practice,…

More than 139 million American population is fully vaccinated, according to the latest Centers for Disease Control and Prevention (CDC) data. While the majority of adults have received the vaccination, some older teens are now receiving COVID-19 vaccination. Pfizer-BioNTech vaccine is available to everyone age 16 and older. To expand the further reach of the vaccine, Pfizer…

AFTER REVIEWING THOROUGHLY, the FDA and CDC concluded that the use of the Johnson & Johnson (J&J) vaccine must resume after a brief pause to review the data on concerning yet rare side effects. Earlier, CDC identified 15 cases of thrombosis, a rare blood clotting condition called TTS or thrombocytopenia syndrome, in people who received…

There is news that Novavax’s maybe the next COVID emergency vaccine to be authorized in the USA. The company plans to file the paperwork in the coming weeks and can beat out other coming vaccinations. Public health officials and researchers expect that the Novavax shot will fill in supply gaps in the U.S. and worldwide…

More than 30 million Americans have received at least a single dose of the COVID-19 vaccine, and it has been very well tolerated and very effective. In December 2020, the FDA approved two COVID-19 vaccines – one by Pfizer and BioNTech, and the other by Moderna. These vaccines appear to have some mild side-effects that…

Pregnant women infected with coronavirus have a higher chance of being admitted to the intensive care unit (ICU), receiving mechanical ventilation, or dying. As the COVID-19 vaccine continues to be available, pregnant ladies must look at their medical histories and risk factors to determine if it’s okay to get the shot. Approximately 4.2 million Americans have…

With the success of five COVID-19 vaccinations in the final stage of trials, millions of Americans will be able to get a shot to treat/ prevent COVID-19. According to the NPR reports, “Moderna, one of the companies leading the race for a safe and effective COVID-19 vaccine, has made deals with other countries to sell the vaccine…